Abstract
poly(vinylpyrrolidone), ethyl cellulose, ES-100, or drug alone. Monolithic 5-FU loaded ES-100 23 fibers were also prepared for comparison. Electron microscopy showed all the fibers to have 24 smooth cylindrical shapes, and clear core-shell structures were visible for all samples except 25 the monolithic fibers. 5-FU was present in the amorphous physical form in all the materials 26 prepared. Dissolution studies showed that the ES-100 shell was not able to prevent drug 27 release at pH 1.0, even though the polymer is completely insoluble at this pH: around 30 to 28 80 % of the maximum drug release was reached after 2h immersion at pH 1.0. These 29 observations are ascribed to the low molecular weight of 5-FU permitting it to diffuse 30 through pores in the ES-100 coating, and the high acid solubility of the drug providing a 31 thermodynamic impetus for this to happen. In addition, the fibers were observed to be 32 broken or merged following 2h at pH 1.0, providing additional escape routes for the 5-FU.
Introduction

42
Electrospinning is a facile technique which has been widely explored in pharmaceutics 43 (Chakraborty et al., 2009; Williams et al., 2012) . In its simplest embodiment, a polymer is 44 dissolved in a volatile solvent and ejected from a syringe fitted with a metal needle 45 (spinneret) towards a metal collector at a controlled rate. The application of a high (kV) 46 voltage between the spinneret and the collector causes the rapid evaporation of solvent, 47 and results in the formation of nanoscale one-dimensional polymer fibers on the collector. If A common way to achieve targeted drug release is to use a pH-sensitive polymer to ensure 60 that the API is freed only in a certain part of the gastro-intestinal tract. The fiber diameters are listed in Table 2 . It can be seen that all the fibers are around 1 µm in 236 size, with the fibers containing S100 and 5-FU solution only as the core being larger than the 237 PVP and EC containing samples. 
239
3.5
In vitro drug release 314 The in vitro drug release profiles of the different fibers are given in Figure 7 . The S2 fibers 315 were not studied in this assay, because the observation of precipitates in the 316 electrospinning process led to concern about their homogeneity. To obtain more insight into the drug release mechanism, the fibers were imaged after 2 h 352 immersion in 0.1 N HCl (see Figure 8 ). 
Discussion
388
In this work, a family of core/shell fibers based on Eudragit S100 has been prepared and 389 fully characterised. We find that the fibers have very distinct core/shell structures, but that 390 even when there is no drug in the shell release at pH 1 is nevertheless rapid. In contrast to 
